Vontobel Holding’s 10x Genomics TXG Stock Holding History

Vontobel Holding’s Portfolio TXG Stock Details TXG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-16,594	Closed	-$1.24M	–	1124
2022 Q1	$1.24M	Buy	16,594 +7,060	+74%	+$618K	0.01%	556
2021 Q4	$1.44M	Hold	9,534	–	–	0.01%	539
2021 Q3	$1.39M	Sell	9,534 -63	-0.7%	-$10.8K	0.01%	539
2021 Q2	$1.93M	Buy	9,597 +8,173	+574%	+$1.48M	0.02%	446
2021 Q1	$257K	Buy	+1,424	New	+$246K	﹤0.01%	860

Other funds holding TXG

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

SIM

SRS Investment Management New York $9.47B AUM 60.12% 1-Year Est. Return

GIM

Generation Investment Management London, United Kingdom $11.2B AUM 0.58% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

Vontobel Holding's TXG Position: Q2 2022 in Review

Vontobel Holding sold out of 10x Genomics (TXG) in Q2 2022, closing a stake of 16,594 shares — an estimated $1.24M sold.

Vontobel Holding first reported a position in TXG in Q1 2021 and held it in 5 quarters. The position peaked at $1.93M in Q2 2021. 254 funds tracked by Wall St. Rank hold TXG as of Q2 2022.

Vontobel Holding reported no remaining 10x Genomics position as of Q2 2022 after selling out during the quarter.
Vontobel Holding sold 16,594 10x Genomics shares in Q2 2022, an estimated $1.24M.
Vontobel Holding first reported a position in 10x Genomics in Q1 2021 and held it in 5 quarters.
Vontobel Holding's 10x Genomics position peaked at $1.93M in Q2 2021.
254 funds tracked by Wall St. Rank held 10x Genomics as of Q2 2022.

Based on Vontobel Holding's 13F filing for Q2 2022, filed 27 Jul 2022.